Monoclonal antibody treatment combo cuts hospitalisation among high-risk Covid patients: Study


PTI, Aug 31, 2021, 1:06 PM IST

A combination of two monoclonal antibody treatments keeps high-risk COVID-19 patients out of the hospital when infected with mild to moderate disease, according to an observational study published in The Lancet’s EClinicalMedicine journal.

Monoclonal antibodies are laboratory-produced molecules engineered to serve as substitute antibodies that can restore, enhance or mimic the immune system’s attack on pathogens.

The combination of the monoclonal antibody treatments — casirivimab and imdevimab — has been given emergency use authorisation (EUA) by the US Food and Drug Administration (FDA). The research enrolled nearly 1,400 patients at Mayo Clinic in the US, of whom 696 received the drug combo between December 2020 and early April while an equal matched cohort did not receive it. The disease status of the patients was evaluated at 14, 21 and 28 days after treatment.

At each point, the numbers for hospitalization were significantly lower in the treated group.

On day 14, 1.3 percent of the treated group were in the hospital, compared to 3.3 percent of those who had not been treated, the researchers said.

On day 21, only 1.3 percent treated were hospitalised, compared to 4.2 per cent of those who had not been treated, they said.

The study found that at the end of 28 days, 1.6 percent of those treated were hospitalised versus 4.8 per cent of those who had not been treated.

This translated to 60-70 percent relative reduction in hospitalisation among treated patients, according to the researchers. Of those who were subsequently hospitalised, the rates of ICU admission and mortality were low, they found.

”Once again, this real-world study suggests that when patients who are at high risk due to a range of comorbidities contract a mild or moderate case of COVID-19, this combination of monoclonal injections gives them a chance of a nonhospitalised recovery. In other words, they recover safely at home,” said Raymond Razonable, an infectious diseases specialist at Mayo Clinic, and senior author of the study.

A previous study by Mayo Clinic researchers suggested the use of bamlanivimab reduced hospitalisations in high-risk patients by 40–60 percent.

That study involved 2,335 treated patients from Mayo Clinic between November of 2020 and February.

Comparing their outcomes with 2,335 untreated patients, the ICU admission and mortality rates also were significantly lower with monoclonal antibody treatment.

The researchers noted that the FDA in April revoked the EUA for bamlanivimab alone and now endorses the use of combination monoclonal antibodies.

”Our conclusion overall at this point is that monoclonal antibodies are an important option in treatment to reduce the impact of COVID-19 in high-risk patients,” Razonable added.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

Nelamangala accident: Police expedite probe, CCTV images being scrutinised

Minister Parameshwara directs police to ensure tight security in Bengaluru on New Year’s eve

Teachings of Lord Christ celebrate love, harmony: PM Modi at Christmas celebrations

Veteran filmmaker Shyam Benegal passes away

Passenger gets back misplaced bag containing valuables worth Rs 20 lakh at Mangaluru airport

Karnataka govt approves 9 industrial projects worth Rs 9,823 Cr

Shami not fully fit yet, ruled out of remaining two Tests in Australia

Related Articles More

‘Faster walkers’ had significantly lower risk of diabetes, hypertension: Study

World Meditation Day 2024: Celebrating inner peace and well-being

Virus causing gut infections could play role in development of Alzheimer’s: Study

Air pollution linked to more hospitalisations for all causes, mental illness too, study finds

Plant-based meat alternatives linked to increased risk of depression in vegetarians, study finds

MUST WATCH

Tulunadu Daivaradane

Feeding Birds with Creative Paddy Art!

Areca Nut

HOTEL SRI DURGA BHAVANA

Harish Poonja


Latest Additions

Kalaburagi: Woman sustains burns after live electric wire falls on her

Nelamangala accident: Police expedite probe, CCTV images being scrutinised

Rohan Estate Mukka – Resort-style luxury layout launched

Minister Parameshwara directs police to ensure tight security in Bengaluru on New Year’s eve

Teachings of Lord Christ celebrate love, harmony: PM Modi at Christmas celebrations

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.